A prevalence-based association test for case-control studies

2008 ◽  
Vol 32 (7) ◽  
pp. 600-605 ◽  
Author(s):  
Kelli K. Ryckman ◽  
Lan Jiang ◽  
Chun Li ◽  
Jacquelaine Bartlett ◽  
Jonathan L. Haines ◽  
...  
Keyword(s):  
Case Control ◽  
Association Test ◽  
Case Control Studies

scholarly journals A fast and powerful tree-based association test for detecting complex joint effects in case–control studies

2014 ◽  
Vol 30 (15) ◽  
pp. 2171-2178 ◽  
Author(s):  
Han Zhang ◽  
William Wheeler ◽  
Zhaoming Wang ◽  
Philip R. Taylor ◽  
Kai Yu
Keyword(s):  
Case Control ◽  
Association Test ◽  
Case Control Studies ◽  
Joint Effects ◽  
Complex Joint

scholarly journals A joint association test for multiple SNPs in genetic case-control studies

2009 ◽  
Vol 33 (2) ◽  
pp. 151-163 ◽  
Author(s):  
Tao Wang ◽  
Howard Jacob ◽  
Soumitra Ghosh ◽  
Xujing Wang ◽  
Zhao-Bang Zeng
Keyword(s):  
Case Control ◽  
Association Test ◽  
Case Control Studies ◽  
Multiple Snps

scholarly journals A Regression-based Association Test for Case-control Studies that Uses Inferred Ancestral Haplotype Similarity

2009 ◽  
Vol 73 (5) ◽  
pp. 520-526 ◽  
Author(s):  
Youfang Liu ◽  
Yi-Ju Li ◽  
Glen A. Satten ◽  
Andrew S. Allen ◽  
Jung-Ying Tzeng
Keyword(s):  
Case Control ◽  
Association Test ◽  
Ancestral Haplotype ◽  
Case Control Studies ◽  
Haplotype Similarity

Case-Control Studies

2009 ◽  
Author(s):  
Ruth H. Keogh ◽  
D. R. Cox
Keyword(s):  
Case Control ◽  
Case Control Studies

Clinical Trials in Thrombosis: Secondary Prevention of Myocardial Infarction

1976 ◽  
Vol 35 (01) ◽  
pp. 049-056 ◽  
Author(s):  
Christian R Klimt ◽  
P. H Doub ◽  
Nancy H Doub
Keyword(s):  
Myocardial Infarction ◽  
Secondary Prevention ◽  
Case Control ◽  
Therapeutic Effects ◽  
Case Control Studies ◽  
Definitive Answer ◽  
Inhibition Of Platelet Aggregation ◽  
Prospective Trials

SummaryNumerous in vivo and in vitro experiments, investigating the inhibition of platelet aggregation and the prevention of experimentally-induced thrombosis, suggest that anti-platelet drugs, such as aspirin or the combination of aspirin and dipyridamole or sulfinpyrazone, may be effective anti-thrombotic agents in man. Since 1971, seven randomized prospective trials and two case-control studies have been referenced in the literature or are currently being conducted, which evaluate the effects of aspirin, sulfinpyrazone, or dipyridamole in combination with aspirin in the secondary prevention of myocardial infarction. A critical review of these trials indicates a range of evidence from no difference to a favorable trend that antiplatelet drugs may serve as anti-thrombotic agents in man. To date, a definitive answer concerning the therapeutic effects of these drugs in the secondary prevention of coronary heart disease is not available.

Association between ALDH2 Gene Polymorphism and Late-onset Alzheimer Disease: An Up-to-date Meta-analysis

2020 ◽  
Vol 17 (2) ◽  
pp. 105-111
Author(s):  
Haitao Liu ◽  
Wei Ge ◽  
Wei Chen ◽  
Xue Kong ◽  
Weiming Jian ◽  
...  
Keyword(s):  
Gene Polymorphism ◽  
Large Scale ◽  
Late Onset ◽  
Meta Analysis ◽  
Case Control ◽  
Cochrane Library ◽  
Positive Trend ◽  
Case Control Studies ◽  
China National Knowledge Infrastructure ◽  
Aldh2 Gene

Objectives: Previous case-control studies have focused on the relationship between ALDH2 gene polymorphism and late-onset Alzheimer's Disease (LOAD), but no definite unified conclusion has been reached. Therefore, the correlation between ALDH2 Glu504Lys polymorphism and LOAD remains controversial. To analyze the correlation between ALDH2 polymorphism and the risk of LOAD, we implemented this up-to-date meta-analysis to assess the probable association. Methods: Studies were searched through China National Knowledge Infrastructure (CNKI), VIP Database for Chinese Technical Periodicals, China Biology Medicine, PubMed, Cochrane Library, Clinical- Trials.gov, Embase, and MEDLINE from January 1, 1994 to December 31, 2018, without any restrictions on language and ethnicity. Results: Five studies of 1057 LOAD patients and 1136 healthy controls met our criteria for the analysis. Statistically, the ALDH2 GA/AA genotype was not linked with raising LOAD risk (odds ratio (OR) = 1.48, 95% confidence interval (CI) = 0.96-2.28, p = 0.07). In subgroup analysis, the phenomenon that men with ALDH2*2 had higher risk for LOAD (OR = 1.72, 95%CI = 1.10-2.67, p = 0.02) was observed. Conclusions: This study comprehends only five existing case-control studies and the result is negative. The positive trend might appear when the sample size is enlarged. In the future, more large-scale casecontrol or cohort studies should be done to enhance the association between ALDH2 polymorphism and AD or other neurodegenerative diseases.

Sign in / Sign up

Export Citation Format

Share Document